PuSH - Publikationsserver des Helmholtz Zentrums München

29 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Marschall, M.* et al.: Differential upregulation of host cell protein kinases by the replication of α-, β- and γ-Herpesviruses provides a signature o virus-specific signalling. J. Gen. Virol. 101, 284-289 (2020)
D'Arienzo, V.* et al.: A PCR assay to quantify patterns of HBV transcription. J. Gen. Virol. 102, DOI: 10.1099/jgv.0.001373 (2019)
de Sousa-Pereira, P. et al.: The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists. J. Gen. Virol. 100, 278-288 (2019)
Ayoubian, H.* et al.: Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation. J. Gen. Virol. 98, 2128-2142 (2017)
Meredith, L.W.* et al.: Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors. J. Gen. Virol. 97, 121-127 (2016)
Yin, R.* et al.: Expression of raf kinase inhibitor protein is down regulated in response to newcastle disease virus infection to promote viral replication. J. Gen. Virol. 96, 2579-2586 (2015)
Hesse, J.* et al.: Suppression of CD8+ T cell recognition in the immediate-early phase of human cytomegalovirus infection. J. Gen. Virol. 94, 376-386 (2013)
Ohno, S. ; Steer, B. ; Sattler, C. & Adler, H.: ORF23 of murine gammaherpesvirus 68 is non-essential for in vitro and in vivo infection. J. Gen. Virol. 93, 1076-1080 (2012)
Haupt, S. et al.: Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines. J. Gen. Virol. 92, 2356-2366 (2011)
Ali, L.* et al.: Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance. J. Gen. Virol. 91, 1931-1938 (2010)
Backes, S.* et al.: Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2α. J. Gen. Virol. 91, 470-482 (2010)
Levin, A.* et al.: A novel role for the viral Rev protein in promoting resistance to superinfection by human immunodeficiency virus type 1. J. Gen. Virol. 91, 1503-1513 (2010)
Roupelieva, M.* et al.: Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex. J. Gen. Virol. 91, 1138-1149 (2010)
Grabusic, K. et al.: The CR4 region of EBNA2 convers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling. J. Gen. Virol. 87, 3169-3176 (2006)
Staib, C. ; Suezer, Y.* ; Kisling, S. ; Kalinke, U.* & Sutter, G.*: Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara. J. Gen. Virol. 87, 2917-2921 (2006)
Schaadt, E. ; Baier, B. ; Mautner, J. ; Bornkamm, G.W. & Adler, B.*: Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J. Gen. Virol. 86, 551-559 (2005)
Staib, C. ; Kisling, S. ; Erfle, V. & Sutter, G.: Inactivation of the viral interleukin 1ß receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J. Gen. Virol. 86, 1997-2006 (2005)
Koopman, G.* et al.: Vaccine protection from CD4⁺ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J. Gen. Virol. 85, 2915-2924 (2004)
Mäkitalo, B.* ; Sutter, G. & Erfle, V.: Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J. Gen. Virol. 85, 2407-2419 (2004)
Nimmerjahn, F. et al.: Active NF-kB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 85, 2347-2356 (2004)